DOCTORS'
Medical Case Studies

type of treatment (VTD combination), followed by high-dose cyclophosphamide (HDC) and autologous stem cell transplantation. The patient's ... (the VTD combination x3), followed by high-dose cyclophosphamide (HDC) and tandem (double) autologous stem cell ("bone ...
and axillary lymph nodes removal . Following IV CMF ( Cyclophosphamide , Methotrexate and Fluorouracil ) every 28 days for 6 ... armpit, and then 4 cycles of AC ( Adriamycin and Cyclophosphamide). One year ago, appeared cerebral, hepatic, right ...
is critical because of cardiac side effects. Cyclophosphamide (Cytoxan) has also been prescribed for severe, ... Natalizumab, Tysabri, Mitoxantrone, Novantrone, Cyclophosphamide, Cytoxan, Corticosteroids, Muscle relaxants, Baclofen, ...
from oral corticosteroids only, followed by oral cyclophosphamide, oral cyclosporine and finally intravenous anti-thymocyte ... Immune suppressive treatment, oral corticosteroids, oral cyclophosphamide, oral cyclosporine, intravenous anti-thymocyte globulin (ATG), ...
On 27 and 28.06 chemotherapy with Vincristine, Cyclophosphamide and Etoposide has been administered. The therapy has been, ...
Curcumin Cyclophoshamide Cyclophospamide Cyclophosphamide Cyclosporine Cyclosporine A Cymbalta ... Oral angiogenesis Oral corticosteroids Oral cyclophosphamide Oral cyclosporine Oral dicumarolics Oral enzyme ...
ADAMTS13 protein. Immunotherapy such as rituximab, cyclophosphamide, and corticosteroids generally do not work quickly enough to ...
HD-VP16 (etoposide) 2.4 g/m 2 HD-EDX (cyclophosphamide) 4 g/m 2 CBDCA 1 (carboplatin) 800 mg/m 2 ...
cortisone, intravenous ceftriaxone , cyclophosphamide , azathioppirne , methotrexate . ... cortisone, intravenous ceftriaxone , cyclophosphamide , azathioppirne , methotrexate . ...
intermediate dose dexamethasone, and continuous low-dose cyclophosphamide is active as well – note that antiviral prophylaxis ... dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma. Br J Haematol 2007; 138:330. ...